AVITA Medical, Inc. (RCEL) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $71.61M | +11.5% |
| 2024 | $64.25M | +28.1% |
| 2023 | $50.14M | +45.7% |
| 2022 | $34.42M | +17.8% |
| 2021 | $29.23M | +104.9% |
| 2020 | $14.26M | +160.6% |
| 2019 | $5.47M | +489.2% |
| 2018 | $929.0K | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $71.61M | +11.5% |
| 2024 | $64.25M | +28.1% |
| 2023 | $50.14M | +45.7% |
| 2022 | $34.42M | +17.8% |
| 2021 | $29.23M | +104.9% |
| 2020 | $14.26M | +160.6% |
| 2019 | $5.47M | +489.2% |
| 2018 | $929.0K | — |